Award
Delivery Order #15B40626F00000106
Takeda Pharmaceuticals Delivery Order for Chemotherapy Care in Orlando
Buyer
Federal Prison System / Bureau of Prisons
Award Amount
$14,385.75
Ceiling
$14,385.75
Awarded
March 01, 2026
Period of Performance
Mar 01, 2026 – Mar 31, 2026
Identifier
15B40626F00000106
NAICS
325412
This award is a delivery order contract issued to Takeda Pharmaceuticals America, Inc., a U.S.-incorporated subsidiary specializing in pharmaceutical products. The contract specifically procures foundation care pharmaceutical chemotherapy products, supporting specialized medical treatment needs. It holds significance for healthcare services provided in Orlando, contributing to the availability of critical chemotherapy medications. The scope includes delivering designated chemotherapy drugs over a one-month period. This delivery order is part of a larger, existing multiple-award contract vehicle under the Federal Supply Schedule, which was competitively awarded to Takeda. The parent contract emphasizes the company's ongoing role in supplying essential pharmaceuticals to government healthcare programs. The delivery order was recently awarded and will be performed within the specified one-month timeframe, reflecting a focused and timely supply effort.
Description
FY26 B1 FOUNDATION CARE PHARM CHEMO MAR 26